News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Sara Ling, RN, PhD

Ms Ling is an Advanced Practice Clinical Leader at CAMH, and a PhD candidate in the Bloomberg School of Nursing at the University of Toronto.

Articles by Sara Ling, RN, PhD

opioid crisis

Harnessing Harm-Reduction Methods to Combat the Opioid Crisis

ByNazanin Izadi, HBSc,Anees Bahji, MD, FRCPC,Nitin Chopra, MD,Sara Ling, RN, PhD,Helena B. Hansen, MD, PhD,Tony P. George, MD, FRCPC

September 14th 2021

Lessons from Novel Harm Reduction Methods

ByNazanin Izadi, HBSc,Anees Bahji, MD, FRCPC,Nitin Chopra, MD,Sara Ling, RN, PhD,Helena B. Hansen, MD, PhD,Tony P. George, MD, FRCPC

June 1st 2021

How can understanding the opioid crisis in Canada inform strategies in the United States?

Latest Updated Articles

Lessons from Novel Harm Reduction Methods
Published: June 1st 2021 | Updated:

Trending on Psychiatric Times

Muscarinic Cholinergic Circuitry in Schizophrenia: Our Evolving Understanding

Physical Activity as a Treatment for Schizophrenia Spectrum Disorders

Adult Age at Diagnosis May Represent a Less Severe Phenotype Than Childhood Diagnosis

Precision Psychiatry in Practice: 3 Therapeutic Drug Monitoring Pearls

Mental Health Grants Cut Then Restored in 24 Hours: Leading Organizations React to Environment of Uncertainty